Clearside Biomedical Profit Margin

The latest profit margin for CLSD is -26.02% as of September 2025. That compares with -4.14% in the prior-year period — down 528.8% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Clearside Biomedical's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLSD's profit margin moved from -4.14% to -26.02% — a 528.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clearside Biomedical's valuation or profitability profile.

Against Healthcare companies, CLSD currently prints -26.02% for profit margin, while the sector average sits near 15.58%. That is roughly 16797.9% below the sector mean. Large gaps often invite a closer look at Clearside Biomedical's growth, margins, and balance sheet.

Profit Margin shows how effectively Clearside Biomedical converts resources into returns. At -26.02%, CLSD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -4.14% in the prior-year period — down 528.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CLSD's profit margin (-26.02%), review year-over-year change from -4.14%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.